| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/22/2007 | WO2006125632A3 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy |
| 02/22/2007 | WO2006121892A3 Diagnosis of liver pathology through assessment of protein glycosylation |
| 02/22/2007 | WO2006118857A3 Methods for analyzing inter-cellular phenomena |
| 02/22/2007 | WO2006113557A3 Gpcr modulators |
| 02/22/2007 | WO2006113289A9 Saposin d and fam3c are biomarkers for alzheimer's disease |
| 02/22/2007 | WO2006109277A3 Determination of partial fill in electrochemical strips |
| 02/22/2007 | WO2006109073A3 Inprovements in or relating to methods and apparatus for analyzing biological samples by mass spectrometry |
| 02/22/2007 | WO2006104474A3 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
| 02/22/2007 | WO2006094023A3 Printing systems and methods |
| 02/22/2007 | WO2006092338A3 Tnf-alpha binding polypeptide , uses thereof and methods employing it |
| 02/22/2007 | WO2006091899A3 Epidermal growth factor receptor mutations |
| 02/22/2007 | WO2006088741A3 Procoagulants based on metal-chelating lipids |
| 02/22/2007 | WO2006085984A3 Immune cell biosensors and methods of using same |
| 02/22/2007 | WO2006084050A3 Libraries and methods for isolating antibodies |
| 02/22/2007 | WO2006084007A3 Novel gene underlying atherosclerosis locus i |
| 02/22/2007 | WO2006083671A3 Bacterial glycolipid activation of cd1d-restricted nkt cells |
| 02/22/2007 | WO2006083269A3 Luminescent nanosensors |
| 02/22/2007 | WO2006081272A3 Compositions and methods for the diagnosis and treatment of tumor |
| 02/22/2007 | WO2006076025A9 Immune cell biosensors and methods of using same |
| 02/22/2007 | WO2006071441A3 Antibodies directed to gpnmb and uses thereof |
| 02/22/2007 | WO2006069203A3 Methods for proteomic profiling using non-natural amino acids |
| 02/22/2007 | WO2006069023A3 Assay method and apparatus with reduced sample matrix effects |
| 02/22/2007 | WO2006066912A9 Detection of a therapeutic antibody in an experimental animal |
| 02/22/2007 | WO2006063028A3 Immunostimulatory compositions and uses thereof |
| 02/22/2007 | WO2006062564A3 Method and apparatus to reduce false positive and false negative identifications of compounds |
| 02/22/2007 | WO2006061640A3 Method of, and apparatus and computer software for imaging biological objects |
| 02/22/2007 | WO2006037059A3 Point-of-care mass spectrometer system |
| 02/22/2007 | WO2006019841A3 Treatment of viral infections with egr 1 activators |
| 02/22/2007 | WO2005121338A9 Anti-perp antibody |
| 02/22/2007 | WO2005089518A3 Uch-l1 expression and cancer therapy |
| 02/22/2007 | WO2005072353A3 Crystal forming devices and systems and methods for making and using the same |
| 02/22/2007 | WO2005042725A3 Liver cancer biomarkers |
| 02/22/2007 | WO2005036123A3 Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte |
| 02/22/2007 | WO2004109445A3 Method and apparatus for automated design of chemical synthesis routes |
| 02/22/2007 | WO2004074436A3 Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer |
| 02/22/2007 | WO2004048543A3 Methods and compositions for controlling valency of phage display |
| 02/22/2007 | WO2004046889A3 System, process and software for producing genome wide maps |
| 02/22/2007 | WO2003073991A3 Methods to increase or decrease bone density |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070044165 Non-human mammal model comprising heterologous nucleated cells - use for screening compounds |
| 02/22/2007 | US20070044163 Interferon gamma-like protein |
| 02/22/2007 | US20070043694 System and method for data analysis, manipulation, and visualization |
| 02/22/2007 | US20070043515 Molecular toxicology modeling |
| 02/22/2007 | US20070043511 Method for generating a hierarchical topological tree of 2D or 3D-structural formulas of chemical compounds for property optimisation of chemical compounds |
| 02/22/2007 | US20070043386 Tissue penetration device |
| 02/22/2007 | US20070043305 Method and apparatus for penetrating tissue |
| 02/22/2007 | US20070043289 Method and Apparatus Including Use of Metalloporphyrins for Subsequent Optimization of Radiosurgery and Radiotherapy |
| 02/22/2007 | US20070043283 Method and Apparatus for Non-Invasive Monitoring of Blood Substances Using Self-Sampled Tears |
| 02/22/2007 | US20070043239 free from recesses formed on an inner surface of a reactor body thereof so as to conduct a stable oxidation reaction therein; reaction production gas is prevented from being condensed and polymerized in the sampling tube, thereby ensuring a long-term stable analysis with a high efficiency |
| 02/22/2007 | US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 02/22/2007 | US20070043208 Crystal structure of erythrocyte binding domain of EBA-175 |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070042982 Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof |
| 02/22/2007 | US20070042981 Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042964 Compositions and methods for modulating connexin hemichannels |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042576 Stable, water-soluble quantum dot, method of preparation and conjugates thereof |
| 02/22/2007 | US20070042507 Composite nanoparticles |
| 02/22/2007 | US20070042506 Apparatus for carrying out an analysis process, in particular for identification of biochemical molecules, and analysis process which can be carried out using this apparatus |
| 02/22/2007 | US20070042505 Liquid crystal based analyte detection |
| 02/22/2007 | US20070042504 Method for determining substance or substances in liquid sample |
| 02/22/2007 | US20070042500 Direct observation of molecular modifications in biological test systems by measuring flourescence lifetime |
| 02/22/2007 | US20070042499 detectors comprising a membrane with an application zone for applying liquid samples,indicator zones, which interact with the analytes and an absorption region, used for qualitative or quantitative analysis of analytes |
| 02/22/2007 | US20070042498 Method for assaying tropolone comprising complexing this molecule with cu (II) |
| 02/22/2007 | US20070042497 Diagnostic methods for determining susceptibility to convulsive conditions |
| 02/22/2007 | US20070042496 Method for acquiring information of a biochip using time of flight secondary ion mass spectrometry and an apparatus for acquiring information for the application thereof |
| 02/22/2007 | US20070042489 Multicompartment apparatus with chambers delinated by low or nonbirefringent glass which utilizes polarized light and distortion in liquid crystal matrices to detect interactions between ligands and receptors |
| 02/22/2007 | US20070042483 Methods and device for adhesive control of internal cell organisation |
| 02/22/2007 | US20070042480 Adding biooxidizable material into reactor having an anode and a cathode and containing anodophilic bacteria in aqueous medium; applying a potential between anode and cathode and collecting hydrogen gas; may be intermittently switched to an electric power generation stage; biocatalysis; biofuel cells |
| 02/22/2007 | US20070042468 Interferon-like protein zcyto21 |
| 02/22/2007 | US20070042449 Qualitative and semi-quantitative detection of a ligand in a sample of a medium to be tested; color reaction obtained by catalysis of a non-coupled or coupled chromogenic compound by a peroxidase enzyme in the presence of hydrogen peroxide produced by the activated apoenzyme; veterinary medicine |
| 02/22/2007 | US20070042448 Use of enzymes from Helicobacter pylori as therapeutical targets |
| 02/22/2007 | US20070042447 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers (divisional) |
| 02/22/2007 | US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 02/22/2007 | US20070042445 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins |
| 02/22/2007 | US20070042444 Multiple-channel test device, method for producing the same and use thereof |
| 02/22/2007 | US20070042443 Hematopoietic cell phenotyping using free circulating cellular markers |
| 02/22/2007 | US20070042442 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 02/22/2007 | US20070042441 Method and apparatus for detecting estradiol and metabolites thereof using an acoustic device |
| 02/22/2007 | US20070042440 Forming a first self-assembled monolayer molecules on an electrode substrate, binding the giant molecule with the functional group, substituting with a second self-assembled monolayer molecules the first self-assembled monolayer molecules, removing |
| 02/22/2007 | US20070042439 Porphyrin compound containing biotinyl group and use thereof |
| 02/22/2007 | US20070042438 Scd4ol and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
| 02/22/2007 | US20070042437 Diagnosis and treatment of Alzheimer's Disease |
| 02/22/2007 | US20070042436 Drug screening for modulators of ADP-ribosyl cyclase activity of CD38 ; inflammation, ischemia, asthma, autoimmune disease, diabetes, arthritis, allergies and transplant rejection |
| 02/22/2007 | US20070042435 Assays for sensory modulators using a sensory cell specific G-protein beta subunit |
| 02/22/2007 | US20070042434 Method for identifying tff2 regulating agents and agents identified using said method |
| 02/22/2007 | US20070042433 Neuregulin protein regulation of synaptic proteins |
| 02/22/2007 | US20070042432 Method of diagnosis and treatment |
| 02/22/2007 | US20070042431 Methods for reducing complexity of a sample using small epitope antibodies |
| 02/22/2007 | US20070042430 Apparatus and method for single-step immunosorbent assay for single and multiple analytes |
| 02/22/2007 | US20070042429 Assay for differentiating Alzheimer's and Alzheimer's-like disorders |
| 02/22/2007 | US20070042428 Treatment of proliferative disorders |
| 02/22/2007 | US20070042427 Microfluidic laminar flow detection strip |
| 02/22/2007 | US20070042426 analyzing at least one of serum amyloid a (SAA) and its variants and transthyretin (TTR) and its variants; cardiovascular disease |
| 02/22/2007 | US20070042425 Diagnostic method for brain damage-related disorders |
| 02/22/2007 | US20070042424 Distinguishing target adiponectin multimer from the other adiponectin multimers by using a protease and/or an antibody; accurately evaluate the relationship between a disease and adiponectin |
| 02/22/2007 | US20070042423 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep-like (rnpep-like) |